Premium
Cancer patients should be considered as a high risk priority target in the coronavirus disease 2019 vaccination process
Author(s) -
Souadka Amine,
Habbat Hajar,
Majbar Mohammed Anass,
Benkabbou Amine,
Amrani Laila,
Ghannam Abdelilah,
El Ahmadi Brahim,
Belkhadir Zakaria Houssaïn,
Mohsine Raouf
Publication year - 2021
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.26508
Subject(s) - medicine , pandemic , vaccination , cancer , disease , intensive care medicine , curfew , clinical trial , immune system , lung cancer , covid-19 , immunology , infectious disease (medical specialty)